Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 4
2013 7
2014 11
2015 21
2016 19
2017 14
2018 20
2019 16
2020 15
2021 15
2022 10
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

138 results

Results by year

Filters applied: . Clear all
Page 1
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer.
Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hamaguchi T, Hasegawa K, Hotta K, Ishida H, Ishiguro M, Ishihara S, Kanemitsu Y, Kinugasa Y, Murofushi K, Nakajima TE, Oka S, Tanaka T, Taniguchi H, Tsuji A, Uehara K, Ueno H, Yamanaka T, Yamazaki K, Yoshida M, Yoshino T, Itabashi M, Sakamaki K, Sano K, Shimada Y, Tanaka S, Uetake H, Yamaguchi S, Yamaguchi N, Kobayashi H, Matsuda K, Kotake K, Sugihara K; Japanese Society for Cancer of the Colon and Rectum. Hashiguchi Y, et al. Among authors: sakamaki k. Int J Clin Oncol. 2020 Jan;25(1):1-42. doi: 10.1007/s10147-019-01485-z. Epub 2019 Jun 15. Int J Clin Oncol. 2020. PMID: 31203527 Free PMC article.
Reply by Authors.
Ito H, Young GJ, Lewis AL, Blair PS, Cotterill N, Lane JA, Sakamaki K, Drake MJ, Abrams P. Ito H, et al. Among authors: sakamaki k. J Urol. 2020 Nov;204(5):1011. doi: 10.1097/JU.0000000000001149.02. Epub 2020 Sep 4. J Urol. 2020. PMID: 32886562 No abstract available.
Tumor steatosis and glutamine synthetase expression in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab therapy.
Kurebayashi Y, Tsujikawa H, Sugimoto K, Yunaiyama D, Araki Y, Saito K, Takahashi H, Kakegawa T, Wada T, Tomita Y, Abe M, Yoshimasu Y, Takeuchi H, Hirata T, Sakamaki K, Kakimi K, Nagao T, Itoi T, Sakamoto M. Kurebayashi Y, et al. Among authors: sakamaki k. Hepatol Res. 2023 Oct;53(10):1008-1020. doi: 10.1111/hepr.13933. Epub 2023 Jun 23. Hepatol Res. 2023. PMID: 37300323
Reply to Iwata and Yoshimura, and Endo.
Yokota I, Sakamaki K, Shane PY, Teshima T. Yokota I, et al. Among authors: sakamaki k. Clin Infect Dis. 2021 Dec 6;73(11):e3986-e3987. doi: 10.1093/cid/ciaa1658. Clin Infect Dis. 2021. PMID: 33104798 No abstract available.
Reply to L. Celio et al.
Ito Y, Tsuda T, Sakamaki K, Nakajima TE. Ito Y, et al. Among authors: sakamaki k. J Clin Oncol. 2018 Sep 10;36(26):2742-2743. doi: 10.1200/JCO.2018.79.1772. Epub 2018 May 25. J Clin Oncol. 2018. PMID: 29799772 No abstract available.
Anticonvulsant action of indazole.
Matsumura N, Kikuchi-Utsumi K, Sakamaki K, Watabe M, Aoyama K, Nakaki T. Matsumura N, et al. Among authors: sakamaki k. Epilepsy Res. 2013 May;104(3):203-16. doi: 10.1016/j.eplepsyres.2012.11.001. Epub 2012 Dec 5. Epilepsy Res. 2013. PMID: 23219048
Predicting Prostate Surgery Outcomes from Standard Clinical Assessments of Lower Urinary Tract Symptoms To Derive Prognostic Symptom and Flowmetry Criteria.
Ito H, Sakamaki K, Young GJ, Blair PS, Hashim H, Lane JA, Kobayashi K, Clout M, Abrams P, Chapple C, Malde S, Drake MJ. Ito H, et al. Among authors: sakamaki k. Eur Urol Focus. 2024 Jan;10(1):197-204. doi: 10.1016/j.euf.2023.06.013. Epub 2023 Jul 15. Eur Urol Focus. 2024. PMID: 37455216 Free article.
138 results